Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Aytu BioPharma Inc Warrants (06/05/2021) (OTC : AYTUW) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan.
Quote
| Last: | $ |
|---|---|
| Change Percent: | |
| Open: | $ |
| Close: | $ |
| High: | $ |
| Low: | $ |
| Volume: | 0 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Stock Data
| Market Cap: | $0 |
|---|---|
| Float: | N/A |
| Insiders Ownership: | N/A |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | |
| Sector: | |
| Country: | |
| City: |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Aytu BioPharma Inc Warrants (06/05/2021) (OTC: AYTUW).
